EcoDrugPlus

Retinoic Acid Receptor Gamma

Ensembl ID : ENSCSEG00000008034
Gene Symbol: RARG
3 Cross references
383 Possible Orthologues:

Retinoid X Receptor Alpha

Ensembl ID : ENSCSEG00000005139
Gene Symbol: RXRA
3 Cross references
231 Possible Orthologues:

Retinoid X Receptor Beta

Ensembl ID : ENSCSEG00000007853
Gene Symbol: RXRB
1 Cross references
211 Possible Orthologues:

Rho-Associated, Coiled-Coil Containing Protein Kinase 2a

Ensembl ID : ENSCSEG00000016179
Gene Symbol: ROCK2A
1 Cross references
216 Possible Orthologues:

Rho-Associated, Coiled-Coil Containing Protein Kinase 2b

Ensembl ID : ENSCSEG00000020966
Gene Symbol: ROCK2B
1 Cross references
214 Possible Orthologues:

Ribosomal Protein L10 Like

Ensembl ID : ENSCSEG00000006831
Gene Symbol: RPL10L
3 Cross references
319 Possible Orthologues:

Ribosomal Protein L10a

Ensembl ID : ENSCSEG00000001886
Gene Symbol: RPL10A
3 Cross references
381 Possible Orthologues:

Ribosomal Protein L11

Ensembl ID : ENSCSEG00000007952
Gene Symbol: RPL11
3 Cross references
288 Possible Orthologues:

Ribosomal Protein L12

Ensembl ID : ENSCSEG00000005988
Gene Symbol: RPL12
3 Cross references
488 Possible Orthologues:

Ribosomal Protein L13

Ensembl ID : ENSCSEG00000008346
Gene Symbol: RPL13
3 Cross references
273 Possible Orthologues:

Ribosomal Protein L14

Ensembl ID : ENSCSEG00000010646
Gene Symbol: RPL14
3 Cross references
310 Possible Orthologues:

Ribosomal Protein L15

Ensembl ID : ENSCSEG00000010378
Gene Symbol: RPL15
3 Cross references
376 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).